Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway.

Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ.

J Virol. 2011 Mar;85(6):2512-23. doi: 10.1128/JVI.01160-10. Epub 2011 Jan 12.

2.

Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.

Prins KC, Delpeut S, Leung DW, Reynard O, Volchkova VA, Reid SP, Ramanan P, Cárdenas WB, Amarasinghe GK, Volchkov VE, Basler CF.

J Virol. 2010 Mar;84(6):3004-15. doi: 10.1128/JVI.02459-09. Epub 2010 Jan 13.

3.

Ebolavirus VP35 is a multifunctional virulence factor.

Leung DW, Prins KC, Basler CF, Amarasinghe GK.

Virulence. 2010 Nov-Dec;1(6):526-31. Epub 2010 Nov 1.

4.

Evasion of interferon responses by Ebola and Marburg viruses.

Basler CF, Amarasinghe GK.

J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076. Review.

5.

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.

Leung LW, Park MS, Martinez O, Valmas C, López CB, Basler CF.

Immunol Cell Biol. 2011 Oct;89(7):792-802. doi: 10.1038/icb.2010.169. Epub 2011 Jan 25.

6.

Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.

Prins KC, Binning JM, Shabman RS, Leung DW, Amarasinghe GK, Basler CF.

J Virol. 2010 Oct;84(20):10581-91. doi: 10.1128/JVI.00925-10. Epub 2010 Aug 4.

7.

Inhibition of Marburg virus protein expression and viral release by RNA interference.

Fowler T, Bamberg S, Möller P, Klenk HD, Meyer TF, Becker S, Rudel T.

J Gen Virol. 2005 Apr;86(Pt 4):1181-8.

PMID:
15784912
8.

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF.

Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010.

9.

Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells.

Zhu Y, Cherukuri NC, Jackel JN, Wu Z, Crary M, Buckley KJ, Bisaro DM, Parris DS.

J Virol. 2012 Mar;86(6):3038-49. doi: 10.1128/JVI.05741-11. Epub 2012 Jan 11.

10.

DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.

Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF.

J Infect Dis. 2011 Nov;204 Suppl 3:S911-8. doi: 10.1093/infdis/jir343.

11.

RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Biedenkopf N, Schlereth J, Grünweller A, Becker S, Hartmann RK.

J Virol. 2016 Jul 27;90(16):7481-96. doi: 10.1128/JVI.00271-16. Print 2016 Aug 15.

12.

The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells.

Nanbo A, Watanabe S, Halfmann P, Kawaoka Y.

Sci Rep. 2013;3:1206. doi: 10.1038/srep01206. Epub 2013 Feb 4.

13.

Mosquito and Drosophila entomobirnaviruses suppress dsRNA- and siRNA-induced RNAi.

van Cleef KW, van Mierlo JT, Miesen P, Overheul GJ, Fros JJ, Schuster S, Marklewitz M, Pijlman GP, Junglen S, van Rij RP.

Nucleic Acids Res. 2014 Jul;42(13):8732-44. doi: 10.1093/nar/gku528. Epub 2014 Jun 17.

14.

Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.

Ilinykh PA, Tigabu B, Ivanov A, Ammosova T, Obukhov Y, Garron T, Kumari N, Kovalskyy D, Platonov MO, Naumchik VS, Freiberg AN, Nekhai S, Bukreyev A.

J Biol Chem. 2014 Aug 15;289(33):22723-38. doi: 10.1074/jbc.M114.575050. Epub 2014 Jun 16.

15.

Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.

Ramanan P, Edwards MR, Shabman RS, Leung DW, Endlich-Frazier AC, Borek DM, Otwinowski Z, Liu G, Huh J, Basler CF, Amarasinghe GK.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20661-6. doi: 10.1073/pnas.1213559109. Epub 2012 Nov 26.

16.

Targeting of dicer-2 and RNA by a viral RNA silencing suppressor in Drosophila cells.

Qi N, Zhang L, Qiu Y, Wang Z, Si J, Liu Y, Xiang X, Xie J, Qin CF, Zhou X, Hu Y.

J Virol. 2012 May;86(10):5763-73. doi: 10.1128/JVI.07229-11. Epub 2012 Mar 21.

17.
19.

Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.

Bale S, Julien JP, Bornholdt ZA, Krois AS, Wilson IA, Saphire EO.

J Virol. 2013 Sep;87(18):10385-8. doi: 10.1128/JVI.01452-13. Epub 2013 Jul 3.

20.

Structure of the Ebola VP35 interferon inhibitory domain.

Leung DW, Ginder ND, Fulton DB, Nix J, Basler CF, Honzatko RB, Amarasinghe GK.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):411-6. doi: 10.1073/pnas.0807854106. Epub 2009 Jan 2.

Supplemental Content

Support Center